LONDON, May 30, 2012 /PRNewswire/ -- Stem cell research is very dynamic with research trends, focus, and approaches evolving extremely rapidly. The tool market has to quickly adapt to these challenges and develop innovative tools that address and accelerate research accomplishments.
New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), Strategic Analysis of the European Stem Cell Research Tools Market, finds that the market earned revenues of $148.4 million in 2011 and estimates this to reach $322.0 million in 2017. The segments covered include: bio-imaging and microscopy, cell biology tools, immunochemical, molecular biology tools, and protein biochemistry tools.
“Firms with the capacity to supply tools for stem cell research will increase as the science matures,” notes Frost & Sullivan Senior Research Analyst Divyaa Ravishankar. “Soon demand and supply will achieve a degree of equilibrium.”
Already, a sizeable stem cell research products market has emerged. Another positive sign for the market has been enhanced industry- academic collaboration.
A key step forward has been the stem cell regulations in a few countries allowing the use of certain cell lines. In some countries such as France, for instance, stem cell regulations are being renewed for the procurement and use of stem cells.
“Such trends indicate the potential for a regulatory climate that would be far less restrictive than the current scenario,” adds Divyaa Ravishankar. “This, together with the prospect of diverse applications within the healthcare arena, is bolstering the future of the market.”
However, the lack of venture capitalists (VC) poses a grave challenge. VC funding is driven by investment concerns, with companies bidding to double their money every few years in order to return revenue to the fund’s investors. As a high risk venture, stem cell technology does not exactly present an attractive investment proposition.
“While these are financial concerns, from the technological standpoint, the challenge remains to understand the basic biology behind stem cells,” remarks Divyaa Ravishankar. “There is an urgent need to design and develop specific technology platforms that enhance the production, genetic stability and integration of transplanted cells.”
If you are interested in more information on this study, please send an e-mail with your contact details to Janique Morvan, Corporate Communications, at janique.morvan@frost.com.
Strategic Analysis of the European Stem Cell Research Tools Market is part of the Clinical Diagnostics Growth Partnership Services programme, which also includes research in the following markets: European PCR Reagent Market for Research and Clinical Diagnostics and European Next Generation Sequencing Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360-degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on “the next big thing”
Register: Gain access to visionary innovation
Strategic Analysis of the European Stem Cell Research Tools Market
M72F-55
Contact:
Janique Morvan
Corporate Communications Europe
P: +33 (0)1 42 81 20 37
M: +33 (0)6 79 22 41 42
E: janique.morvan@frost.com
http://www.frost.com
SOURCE Frost & Sullivan
